ANAVEX portfolio is based on the extensive research of the company's Scientific Founder and his colleagues, who have built and continue to establish key collaborations with leading research and academic institutions. This resulted in a unique strategy for the identification of novel and powerful drug candidates with increased probability of success. This provides ANAVEX with a flexible and effective network that continually feeds the company's development pipeline, enabling it to dynamically address the current unmet needs of the pharmaceutical market.